Key result
A polypill strategy providing effective control of both blood pressure and lipid profile allows for controlling several factors of the cardiovascular continuum and contributes to higher patient adherence to treatment.
Why the study?
The combined effect of dyslipidemia and high blood pressure significantly contributes to cardiovascular diseases, making simultaneous control of these risk factors a priority in primary and secondary prevention.
Answers are grounded in this paper and cite their sources.
The use of a polypill combining antihypertensive and lipid-lowering medications, such as perindopril, indapamide, and rosuvastatin, improves adherence and helps achieve target blood pressure and lipid levels in cardiovascular prevention.
The combined effect of dyslipidemia and high blood pressure largely contributes to the development and progression of cardiovascular diseases, and therefore the control of these risk factors should be a priority strategy both within primary and secondary prevention. A concept of a polypill, which provides effective control of both blood pressure and lipid profile, is a promising strategy. It allows of controlling several factors of the cardiovascular continuum, and contributes to a higher patient adherence to treatment. Therefore, the wider implementation of a polypill strategy will improve patients’ prognosis and quality of life.
No takes yet. Share an insight, caveat, or question.
Конради et al. (2021) conducted a review in Hypertension and dyslipidemia. Polypill (fixed-dose combination) vs. Usual care was evaluated. A polypill strategy providing effective control of both blood pressure and lipid profile allows for controlling several factors of the cardiovascular continuum and contributes to higher patient adherence to treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: